Construction Of ‘Human Antibody’ Disputed In New Federal Circuit Appeal
WASHINGTON, D.C. — In a July 25 appellant brief, Immunex Corp. maintains that the Patent Trial and Appeal Board erred by not construing “human antibody” as limited to fully human antibodies,...To view the full article, register now.
Already a subscriber? Click here to view full article